Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Chondrosarcoma × apatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 5 Drug-Related Side Effects and Adverse Reactions 2 Colorectal Neoplasms 2 Advanced Gastric Cancer 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Quality of Life 1 Peritoneal Metastases From Gastric Cancer 1 Ovarian Cancer Recurrent 1 Osteosarcoma 1 Meningioma 1 Immune Checkpoint Inhibition 1 Gastrointestinal Stromal Tumors 1 Esophageal Neoplasms 1 Chondrosarcoma 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Gastric Adenocarcinoma 1

Interventions

regorafenib 1 apatinib 1 Standard of Care 1 Proton Therapy 1 Pentetic Acid 1 Palliative Care 1 Nutritional Support 1 Minocycline 1 IPI-926 1 Heparin 1 Glutamine 1 Gelclair 1 Celecoxib 1 Analgesia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04260113 2021-01-05

AIAC

Peking University People's Hospital

Phase NA Completed

Chondrosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡